Rockwell Medical has entered into a multi-year supply pact with DaVita, a provider of kidney care in the US.
Subscribe to our email newsletter
Rockwell Medical is a biopharmaceutical company that offers products and services initially targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia.
The company is engaged in developing a proprietary renal drug therapy for treating iron deficiency in ESRD patients on dialysis.
Rockwell Medical chairman and CEO Robert Chioini said they are pleased to have executed this multi-year supply agreement with DaVita, further strengthening their business relationship.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.